Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO

Core Viewpoint - Hisamitsu Pharmaceutical is planning a management buyout to take the company private for nearly 400 billion yen ($2.55 billion) [1] Company Summary - Hisamitsu Pharmaceutical aims to execute a management buyout, indicating a strategic shift towards privatization [1] - The buyout is valued at approximately 400 billion yen, equivalent to $2.55 billion, highlighting the significant financial commitment involved [1]